Moxley Rodney A, Smith David R, Luebbe Matt, Erickson Galen E, Klopfenstein Terry J, Rogan Dragan
Department of Veterinary and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0905, USA.
Foodborne Pathog Dis. 2009 Sep;6(7):879-84. doi: 10.1089/fpd.2009.0297.
A clinical trial conducted during the summer of 2006 evaluated effects of two- and three-dose regimens of an Escherichia coli O157 vaccine product on the probability of detecting E. coli O157:H7 in feces and colonization of the terminal rectum. The three-dose regimen significantly reduced the probability for cattle to shed E. coli O157:H7 in feces 65% compared to placebo-treated cattle. A dose-effect was demonstrated because a two-dose regimen of the vaccine product was intermediate in effect. These results are consistent with previous estimates of vaccine efficacy against fecal shedding, and agree with our previous finding that efficacy of two or three doses of this vaccine product exhibit a dose-response.
2006年夏季进行的一项临床试验评估了一种大肠杆菌O157疫苗产品的两剂和三剂接种方案对粪便中检测出大肠杆菌O157:H7的概率以及直肠末端定植的影响。与接受安慰剂治疗的牛相比,三剂接种方案显著降低了牛粪便中排出大肠杆菌O157:H7的概率,降低了65%。由于该疫苗产品的两剂接种方案效果处于中间水平,因此证明了剂量效应。这些结果与之前针对粪便排菌的疫苗效力估计一致,并且与我们之前的发现相符,即该疫苗产品两剂或三剂的效力呈现剂量反应。